FINGLA GROUP
FINNISH BONE GLASS RESEARCH GROUP
"Our vision in FINGLA is to shape future healthcare through high level evidence-based materials science research in the field of bone formation and infection treatment."
Nina Lindfors
Group Leader
From laboratory to the patient
Due to increasing antibacterial resistance and health care costs, new materials with increased biomechanical and surface reactive properties are needed for the treatment of demanding bone and soft tissue defects, as well as a better understanding of the materials in clinical use. In FINGLA connected to the Helsinki University Hospital and the University of Helsinki, preclinical and clinical biomaterial research in the field of bioactive glass (BAG) has been conducted for almost two decades to increase knowledge about BAG and to improve and develop new materials for tissue reconstruction and infection treatment.